CCR7 and neoplasm: It has previously been demonstrated that a population of CD56dimCD57+CD69+CCR7+KIR+ NK cells are expanded in tumour infiltrated lymph nodes of patients with melanoma, and that these NK cells are key effectors of anti-tumoral cytotoxicity66.